These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19028872)

  • 1. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways.
    Inceoglu B; Jinks SL; Ulu A; Hegedus CM; Georgi K; Schmelzer KR; Wagner K; Jones PD; Morisseau C; Hammock BD
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18901-6. PubMed ID: 19028872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.
    Inceoglu B; Zolkowska D; Yoo HJ; Wagner KM; Yang J; Hackett E; Hwang SH; Lee KS; Rogawski MA; Morisseau C; Hammock BD
    PLoS One; 2013; 8(12):e80922. PubMed ID: 24349022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multimodal disease modifying approach to treat neuropathic pain--inhibition of soluble epoxide hydrolase (sEH).
    Pillarisetti S; Khanna I
    Drug Discov Today; 2015 Nov; 20(11):1382-90. PubMed ID: 26259523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
    Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
    Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.
    Wagner K; Inceoglu B; Hammock BD
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):76-83. PubMed ID: 21854866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
    Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
    Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
    J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
    Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus.
    Wu HF; Chen YJ; Wu SZ; Lee CW; Chen IT; Lee YC; Huang CC; Hsing CH; Tang CW; Lin HC
    Neural Plast; 2017; 2017():3467805. PubMed ID: 29138698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxyeicosatrienoic acids and soluble epoxide hydrolase in physiology and diseases of the central nervous system.
    Kuo YM; Lee YH
    Chin J Physiol; 2022; 65(1):1-11. PubMed ID: 35229747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
    Elmarakby AA
    Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R321-30. PubMed ID: 22116511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
    Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
    Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
    Shi Z; He Z; Wang DW
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
    Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
    Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.